Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Laboratory Corporation Of America Holdings (LH)
NYSE:LH
Holding LH?
Track your performance easily
LH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$191.97 - $238.47
Previous Close$227.22
Volume584.27K
Average Volume (3M)565.22K
Market Cap
$19.08B
Enterprise Value$22.77B
Total Cash (Recent Filing)$265.10M
Total Debt (Recent Filing)$3.96B
Price to Earnings (P/E)43.1
Beta0.70
Next Earnings
Oct 24, 2024EPS Estimate
$3.54Last Dividend Ex-Date
Aug 29, 2024Dividend Yield1.27%
Share Statistics
EPS (TTM)5.26
Shares Outstanding83,963,277
10 Day Avg. Volume568,937
30 Day Avg. Volume565,224
Standard Deviation0.09
R-Squared0.41
Alpha-0.00346
Financial Highlights & Ratios
Price to Book (P/B)-2.29
Price to Sales (P/S)1.53
Price to Cash Flow (P/CF)8.50
P/FCF Ratio10.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.82
Enterprise Value/Gross Profit6.77
Enterprise Value/Ebitda14.51
Forecast
1Y Price Target
$257.44Price Target Upside14.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
Laboratory News
PremiumCompany Announcements
Labcorp Executives to Present at Global Healthcare Conference
Bulls Say, Bears Say
Bulls Say
AcquisitionsManagement remains excited about the Invitae acquisition as integration is ongoing.
Financial PerformanceUpdated FY24 guidance included a higher sales range on a stronger Diagnostics segment expectation and Invitae contribution.
Share RepurchaseThe company also announced a $1bn increase to its share repurchase authorization.
Bears Say
Earnings2024 earnings are expected to be dilutive primarily due to the Invitae acquisition.
Financial PerformanceThe Early Development segment declined meaningfully, with quarterly revenue dropping 15% due to higher levels of cancellations and lower orders.
RevenueThe Biopharma segment underperformed expectations, with sales of $707 million versus an expected $715 million and ending backlog down by -0.6%.
---
Ownership Overview
1.45% Insiders
31.16% Mutual Funds
46.59% Other Institutional Investors
20.80% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LH FAQ
What was Laboratory Corporation Of America Holdings’s price range in the past 12 months?
Laboratory Corporation Of America Holdings lowest stock price was $191.97 and its highest was $238.47 in the past 12 months.
What is Laboratory Corporation Of America Holdings’s market cap?
Currently, no data Available
When is Laboratory Corporation Of America Holdings’s upcoming earnings report date?
Laboratory Corporation Of America Holdings’s upcoming earnings report date is Oct 24, 2024 which is in 34 days.
How were Laboratory Corporation Of America Holdings’s earnings last quarter?
Laboratory Corporation Of America Holdings released its earnings results on Aug 01, 2024. The company reported $3.94 earnings per share for the quarter, beating the consensus estimate of $3.776 by $0.164.
Is Laboratory Corporation Of America Holdings overvalued?
According to Wall Street analysts Laboratory Corporation Of America Holdings’s price is currently Undervalued.
Does Laboratory Corporation Of America Holdings pay dividends?
Laboratory Corporation Of America Holdings pays a Quarterly dividend of $0.72 which represents an annual dividend yield of 1.27%. See more information on Laboratory Corporation Of America Holdings dividends here
What is Laboratory Corporation Of America Holdings’s EPS estimate?
Laboratory Corporation Of America Holdings’s EPS estimate is $3.54.
How many shares outstanding does Laboratory Corporation Of America Holdings have?
Laboratory Corporation Of America Holdings has 83,963,280 shares outstanding.
What happened to Laboratory Corporation Of America Holdings’s price movement after its last earnings report?
Laboratory Corporation Of America Holdings reported an EPS of $3.94 in its last earnings report, beating expectations of $3.776. Following the earnings report the stock price went up 8.33%.
Which hedge fund is a major shareholder of Laboratory Corporation Of America Holdings?
Among the largest hedge funds holding Laboratory Corporation Of America Holdings’s share is Diamond Hill Capital Management Inc. It holds Laboratory Corporation Of America Holdings’s shares valued at 397M.
---
Laboratory Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$257.44 (14.63% Upside)
$257.44 (14.63% Upside)
Hedge Fund Trend
Increased
By 420.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $6.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 1.5%
Last 30 Days ▲ 0.5%
Last 30 Days ▲ 0.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
14.48%
12-Months-Change
Fundamentals
Return on Equity
5.35%
Trailing 12-Months
Asset Growth
-5.68%
Trailing 12-Months
Company Description
Laboratory Corporation Of America Holdings
Laboratory Corp. of America Holdings is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment involves in providing drug development solutions, to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.
---
LH Company Deck
---
LH Earnings Call
Q2 2024
0:00 / 0:00
---
LH Revenue Breakdown
77.42% Dx
22.81% BLS
---
LH Stock 12 Month Forecast
Average Price Target
$257.44
▲(14.63% Upside)
Technical Analysis
Best Analysts Covering LH
1 Year
1 Year Success Rate
17/20 ratings generated profit
1 Year Average Return
+14.68%
reiterated a buy rating 2 months ago
Copying Erin Wright's trades and holding each position for 1 Year would result in 85.00% of your transactions generating a profit, with an average return of +14.68% per trade.
---